Pierre Pharma Plus Pvt Ltd has signed a commercial agreement with MedGenesis Ltd (UK) to bring TARA PV to the Asia-Pacific region, with a primary focus on India.

This partnership marks an important step toward making compliant, enterprise-grade pharmacovigilance technology more accessible to emerging biotechs, CROs, and PV service providers.

Why This Partnership Matters

Regardless of the size of an organisation, pharmaceutical sponsors face the same fundamental regulatory responsibilities—from E2B(R3) submissions and CIOMS forms to PSURs and DSURs. However, sophisticated safety databases have traditionally been designed and priced primarily for larger global pharmaceutical companies.

TARA PV is designed to address this gap. The platform brings essential pharmacovigilance capabilities together in a single system.

Key TARA PV Capabilities

  • Regulatory Reporting: E2B(R3), CIOMS, MedWatch, PSUR and DSUR reporting in one system.
  • Integrated Dictionaries: MedDRA, WHO Drug and PubMed dictionaries integrated into the platform.
  • Multi-Tenancy: Enables CROs to keep each sponsor’s data and operations clearly separated.
  • Compliance: 21 CFR Part 11-enabled functionality with GxP and ICH alignment.
  • Hosted & Pre-Validated: The solution is hosted and pre-validated by the vendor, helping reduce the validation burden on QA teams.

Local Support in India

Through this partnership, Pierre Pharma Plus will provide local support across India, including:

  • Implementation support
  • Legacy data migration
  • Validation and UAT support
  • User training
  • First-line support during India working hours

Supporting the Pharmacovigilance Community

The collaboration is particularly relevant for CROs, emerging biotech companies and pharmacovigilance service providers looking for a compliant and scalable safety database without the cost and complexity traditionally associated with enterprise solutions.

Pierre Pharma Plus looks forward to working with MedGenesis to make modern pharmacovigilance technology more accessible across India and the wider Asia-Pacific market.

Learn More About TARA PV

If you are responsible for drug safety at a CRO, emerging biotech company or PV service provider and are looking for a compliant safety database solution, get in touch with Pierre Pharma Plus to learn more about TARA PV and arrange a walkthrough.

We are grateful to the MedGenesis team for their confidence in Pierre Pharma Plus and look forward to what this partnership will bring.